Clinical Trial Update: Study to Define Safety and Effectiveness of Dolutegravir (DTG) Use in Human Immunodeficiency Virus (HIV) Positive Pregnant Women

View source ↗

Summary

A clinical trial is studying the safety and effectiveness of dolutegravir use in HIV-positive pregnant women; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tivicay (dolutegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Status: RECRUITING